MEDICOX Co. Ltd (054180) - Cash Flow Conversion Efficiency

Latest as of March 2025: -0.040x

Based on the latest financial reports, MEDICOX Co. Ltd (054180) has a cash flow conversion efficiency ratio of -0.040x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.26 Billion ≈ $-1.53 Million USD) by net assets (₩56.22 Billion ≈ $38.10 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

MEDICOX Co. Ltd - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how MEDICOX Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read MEDICOX Co. Ltd total liabilities for a breakdown of total debt and financial obligations.

MEDICOX Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of MEDICOX Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Gyldendal A/S CO:GYLD-B	0.262x
Faron Pharmaceuticals Oy LSE:FARN	0.000x
Chariot Oil & Gas Limited LSE:CHAR	-0.127x
PROMIS NEUROSCIENCES F:23J0	N/A
STV Group plc LSE:STVG	-0.602x
Ireka Corporation Bhd KLSE:8834	0.003x
Reliance Industries Limited IL:RIGD	N/A
Staffline Group Plc LSE:STAF	-0.220x

Annual Cash Flow Conversion Efficiency for MEDICOX Co. Ltd (2012–2024)

The table below shows the annual cash flow conversion efficiency of MEDICOX Co. Ltd from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see 054180 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩52.45 Billion ≈ $35.54 Million	₩-6.63 Billion ≈ $-4.50 Million	-0.126x	+11.47%
2023-12-31	₩62.24 Billion ≈ $42.18 Million	₩-8.89 Billion ≈ $-6.03 Million	-0.143x	+1.32%
2022-12-31	₩63.24 Billion ≈ $42.86 Million	₩-9.16 Billion ≈ $-6.20 Million	-0.145x	-32.31%
2021-12-31	₩66.20 Billion ≈ $44.87 Million	₩-7.24 Billion ≈ $-4.91 Million	-0.109x	+4.37%
2020-12-31	₩37.90 Billion ≈ $25.68 Million	₩-4.34 Billion ≈ $-2.94 Million	-0.114x	+23.98%
2019-12-31	₩21.17 Billion ≈ $14.34 Million	₩-3.19 Billion ≈ $-2.16 Million	-0.151x	-1297.78%
2018-12-31	₩21.22 Billion ≈ $14.38 Million	₩266.71 Million ≈ $180.74K	0.013x	+106.25%
2017-12-31	₩16.55 Billion ≈ $11.21 Million	₩-3.33 Billion ≈ $-2.25 Million	-0.201x	-835.66%
2016-12-31	₩19.11 Billion ≈ $12.95 Million	₩522.30 Million ≈ $353.96K	0.027x	-67.46%
2015-12-31	₩21.70 Billion ≈ $14.71 Million	₩1.82 Billion ≈ $1.23 Million	0.084x	+6.34%
2014-12-31	₩20.74 Billion ≈ $14.06 Million	₩1.64 Billion ≈ $1.11 Million	0.079x	+5.26%
2012-12-31	₩15.44 Billion ≈ $10.46 Million	₩1.16 Billion ≈ $785.10K	0.075x	--

About MEDICOX Co. Ltd

KQ:054180 Korea Aerospace & Defense

Market Cap

$573.12K

₩845.71 Million KRW

Market Cap Rank

#30502 Global

#2045 in Korea

Share Price

₩153.00

Change (1 day)

-10.53%

52-Week Range

₩104.00 - ₩269.00

All Time High

₩30388.84